CLSA Downgrades Emerson (EMR) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures sink as AI doubts resurface, oil jumps
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
Tweet
Share
E-mail
Get Alerts EMR Hot Sheet
Price: $163.11 --0%
Rating Summary:
27 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 9 | New: 44
Rating Summary:
27 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 9 | New: 44
Join SI Premium – FREE
CLSA downgraded Emerson (NYSE: EMR) from Underperform to Sell.
For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.
Shares of Emerson closed at $53.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Argus Downgrades Alcoa (AA) to Hold
- JPMorgan Downgrades Qiagen NV (QGEN) to Neutral
- UBS Downgrades Carrefour SA (CA:FP) (CRRFY) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
